。 容而產生或因倚賴該等內容而引致的任何損失承擔任何責任 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 （於中華人民共和國註冊成立之股份有限公司） （股份代號：133 9） 海外監管公告 第13.10B條的披露義務而作出。 本公告乃中國人民保險集團股份有限公司根據《香港聯合交易所有限公司證券上市規則》 茲載列該公告如下，僅供參閱。 承董事會命 中國人民保險集團股份有限公司 伍秀薇 公司秘书 中國北京，二零二五年十二月四日 於本公告日，本公司執行董事為趙鵬先生、李祝用先生及肖建友先生，非執行董事為王 清劍先生、苗福生先生、王少群先生、喻強先生及宋洪軍先生，獨立非執行董事為邵善 波先生、高永文先生、崔歷女士、徐麗娜女士及王鵬程先生。 证券代码：601319 证券简称：中国人保 公告编号：2025-039 中国人民保险集团股份有限公司 2025年半年度权益分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提 ...

12月4日金融一线消息，中国人保公告称，2025年半年度利润分配方案已获2025年第二次临时股东会审 议通过。本次以总股本44，223，990，583股为基数，每股派发现金红利0.075元（含税），共计派发现 金红利3.32亿元，其中A股派发现金红利约26.62亿元。A股股权登记日为2025年12月11日，除权（息） 日和现金红利发放日为12月12日。除财政部及社保基金理事会自行发放外，其他A股股东委托中国结算 上海分公司派发。 | 股份类别 | 股权登记日 | 最后交易日 | 除权(息)日 现金红利发放日 | | | --- | --- | --- | --- | --- | | A P | 2025/12/11 | | 2025/12/12 | 2025/12/12 | 责任编辑：秦艺 12月4日金融一线消息，中国人保公告称，2025年半年度利润分配方案已获2025年第二次临时股东会审 议通过。本次以总股本44，223，990，583股为基数，每股派发现金红利0.075元（含税），共计派发现 金红利3.32亿元，其中A股派发现金红利约26.62亿元。A股股权登记日为2025年12月11日，除权（息） 日和 ...

证券代码：601319 证券简称：中国人保 公告编号：2025-039 中国人民保险集团股份有限公司 2025年半年度权益分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 每股分配比例 差异化分红送转： 否 一、 通过分配方案的股东会届次和日期 本次利润分配方案经公司2025 年 10 月 30 日的2025年第二次临时股东会审议通过。 二、 分配方案 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任公司上海分 公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 本公司 H 股股东的 现金红利发放的具体操作不适用本公告，其详情请参阅本公司于 2025 年 10 月 10 日及 10 月 30 日在香港联合交易所有限公司网站（www.hkexnews.hk）刊发的相关公告。 A 股每股现金红利0.075元（含税） 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- ...

格隆汇12月4日丨中国人保(601319.SH)公布2025年半年度权益分派实施公告，本次利润分配以方案实施 前的公司总股本442.24亿股为基数，每股派发现金红利0.075元（含税），共计派发现金红利33.17亿 元。其中，A股普通股股份数为354.98亿股，本次派发A股现金红利共计约人民币26.62亿元。 MACD金叉信号形成，这些股涨势不错！ 本次权益分派股权登记日为：2025年12月11日，除权除息日为：2025年12月12日。 ...

中国人保公告称，2025年半年度利润分配方案已获2025年第二次临时股东会审议通过。本次以总股本 44,223,990,583股为基数，每股派发现金红利0.075元（含税），共计派发现金红利3.32亿元，其中A股派 发现金红利约26.62亿元。A股股权登记日为2025年12月11日，除权（息）日和现金红利发放日为12月12 日。除财政部及社保基金理事会自行发放外，其他A股股东委托中国结算上海分公司派发。 ...

二、中国人民财产保险股份有限公司临夏州分公司应按照有关规定及时办理变更及许可证换领事宜。 一、同意中国人民财产保险股份有限公司永靖支公司川南营销服务部营业场所变更为：甘肃省临夏回族 自治州永靖县刘家峡镇川南路永靖令牌优家国际1号楼1单元1层商铺109室。 2025年12月1日，国家金融监督管理总局临夏监管分局发布批复称，《中国人民财产保险股份有限公司 临夏州分公司关于永靖支公司川南营销服务部营业场所变更的请示》（临人保财险发〔2025〕60号）收 悉。经审核，现批复如下： ...

Core Insights - The total issuance of technology innovation bonds in the market has reached approximately 1.5 trillion yuan, with funds accelerating towards technology innovation entities [1] - The establishment of an 800 billion yuan re-lending program for technology innovation and technological transformation by the Ministry of Science and Technology and the People's Bank of China aims to support over 120,000 technology-based SMEs [1] - The implementation of the "Innovation Points System" and specialized guarantee plans has led to positive outcomes in financial support for major national technology tasks and technology-based SMEs [1] Group 1: Technology Financial System Development - The establishment of a "Technology Board" in the bond market is a key focus for building a technology financial system that aligns with technological innovation, aiming to raise long-term, low-interest, and easily accessible bond funds [2] - Shenzhen has taken the lead in responding to the "Technology Board," issuing a total of 1 billion yuan in technology innovation bonds, primarily targeting cutting-edge fields such as artificial intelligence and biomedicine [2] - The "Investment-Insurance Linkage" model by Shenzhen High-tech Investment Group provides comprehensive services including equity, debt, and diversified financial tools to support startups and small enterprises [2] Group 2: Bond Issuance and Financial Products - Guangdong has issued 102 technology innovation bonds with a total issuance scale of 111.4 billion yuan, ranking second nationwide, with most funds directed towards technology innovation-related fields [3] - The bond market's "Technology Board" leverages its market-oriented advantages to continuously introduce specialized innovative products to support financing for technology-based enterprises [3] - A multi-layered and diversified technology financial service system is being developed to better meet the financing needs of technology-based enterprises at different stages [3] Group 3: Financial Support Mechanisms - The establishment of a coordinated mechanism for technology finance has improved the matching and precision of financial support for technology innovation [4] - A comprehensive financial service plan called "Mid-Stage Insurance and Financing" has been launched, providing 100 billion yuan in bank support and insurance guarantees for mid-stage projects over the next three years [4] - The "拨保贷投" mechanism provides full lifecycle funding support for mid-stage projects, covering various funding needs from project inception to maturity [5] Group 4: Innovation Points System - The "Innovation Points System" is being promoted nationwide to optimize evaluation indicators and provide precise profiles for technology-based SMEs [6] - In Handan, the "科创数智贷" product allows companies to secure loans based on their innovation points ranking, demonstrating the effectiveness of the innovation points system [7] - The upgraded "Innovation Points System 2.0" aims to convert a company's innovation potential into quantifiable credit for financial institutions, enhancing the accessibility and efficiency of technology financial services [8] Group 5: Knowledge Value Credit - Hubei has established a knowledge value credit evaluation model, allowing companies to secure financing based solely on intellectual property and talent value [9] - The "Knowledge Value Credit Loan" program has issued a total of 77.4 billion yuan, supporting 14,916 technology-based enterprises, breaking the traditional asset-backed financing model [11] - The establishment of a risk compensation fund and a scientific knowledge value credit evaluation system has enhanced banks' willingness to lend to technology-based enterprises [10][11]

Core Insights - The long-term investment return assumption is a crucial parameter affecting the intrinsic value of life insurance companies, reflecting their expectations regarding capital market conditions and investment strategies. In 2024, most life insurance companies have lowered their long-term investment return assumption from 4.5% to 4.0% [9][11]. Investment Returns Analysis - From 2010 to 2024, listed life insurance companies had a total investment return that exceeded the long-term investment return assumption in only 5 out of 15 years, with the remaining 10 years showing negative deviations. The cumulative total investment return deviation for the industry is -0.38% [3][6][37]. - As of the first three quarters of 2025, the total investment return for the year is approximately 3.5%, slightly below the long-term investment return assumption of 4.0%. A strong performance in the fourth quarter could make 2025 the first year since 2020 to exceed the long-term investment return assumption [3][13]. Company-Specific Performance - In 2024, China Life's total investment return was 4.02%, while its comprehensive investment return was 5.94%, both exceeding the long-term investment return assumption of 4.0% [17][18]. - Ping An Life's total investment return for 2024 was 3.32%, with a comprehensive investment return of 7.25%, also above the long-term assumption [19][21]. - For 2024, Taikang Life's total investment return was 3.03%, while its comprehensive investment return was 7.33%, surpassing the long-term assumption [22][23]. - New China Life reported a total investment return of 3.56% and a comprehensive investment return of 6.84% for 2024, both exceeding the long-term assumption [24][25]. - PICC Life's total investment return was 3.70%, with a comprehensive investment return of 14.1%, significantly above the long-term assumption [28][29]. - AIA's estimated long-term investment return assumption for 2024 is 3.4%, which is below the 4.0% threshold, indicating a cautious outlook [30][33]. Summary of Deviations - The average deviation of total investment returns from long-term assumptions for the industry is -0.38%, while the average deviation for comprehensive investment returns is 0.66%. Companies like PICC Life and AIA show better performance with positive deviations [37][38].

来源：新浪基金∞工作室 12月3日，港股高股息ETF（159302）收盘跌0.66%，成交额1936.00万元。 港股高股息ETF（159302）成立于2024年8月23日，基金全称为银华中证港股通高股息投资交易型开放 式指数证券投资基金，基金简称为港股高股息ETF。该基金管理费率每年0.50%，托管费率每年0.10%。 港股高股息ETF（159302）业绩比较基准为中证港股通高股息投资指数收益率(经估值汇率调整)。 规模方面，截止12月2日，港股高股息ETF（159302）最新份额为9579.76万份，最新规模为1.30亿元。 回顾2024年12月31日，港股高股息ETF（159302）份额为1.09亿份，规模为1.21亿元。即该基金今年以 来份额减少11.95%，规模增加7.95%。 流动性方面，截止12月3日，港股高股息ETF（159302）近20个交易日累计成交金额3.54亿元，日均成 交金额1770.87万元；今年以来，223个交易日，累计成交金额29.14亿元，日均成交金额1306.93万元。 港股高股息ETF（159302）现任基金经理为张亦驰。张亦驰自2024年8月23日管理（或拟管理）该基 ...

Market Overview - The Hong Kong stock market experienced a significant decline, with the Hang Seng Index falling by 1.28% to close at 25,760.73 points, while the Hang Seng China Enterprises Index and the Hang Seng Tech Index dropped by 1.68% and 1.58%, respectively [1][2]. Sector Performance - Major technology stocks and large financial stocks collectively dragged down market sentiment, with notable declines in companies like Bilibili (-3%), NetEase (-2.94%), and Alibaba (-2.17%) [4][5]. - The financial sector also faced losses, particularly in insurance stocks, with China Pacific Insurance down by 4% and China Life Insurance down by over 3% [6]. - The biopharmaceutical sector saw declines, with WuXi AppTec falling by over 3% and other major players like BeiGene and WuXi Biologics also experiencing losses [7]. Commodity and Other Stocks - In contrast, stocks in the non-ferrous metals and precious metals sectors performed well, with China Molybdenum and China Aluminum rising by over 2% [8]. - Airline stocks strengthened, with China Eastern Airlines and China Southern Airlines both gaining over 2%, supported by a new action plan promoting the integration of cultural tourism and civil aviation [9]. Capital Flows - Southbound capital saw a net inflow of 2.279 billion HKD, indicating continued interest in Hong Kong stocks from mainland investors [9]. Future Outlook - Analysts suggest that the current market adjustments may create opportunities for recovery in 2026, with expectations of a necessary interest rate cut in December due to rising unemployment and declining real wages [11].